Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 29.3 USD 0.76% Market Closed
Market Cap: 14.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Net Margin
Baxter International Inc

0.8%
Current
3%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.8%
=
Net Income
108m
/
Revenue
14B

Net Margin Across Competitors

Country US
Market Cap 14.9B USD
Net Margin
1%
Country US
Market Cap 199.9B USD
Net Margin
14%
Country US
Market Cap 191.9B USD
Net Margin
29%
Country US
Market Cap 140.8B USD
Net Margin
16%
Country US
Market Cap 134.7B USD
Net Margin
11%
Country IE
Market Cap 104.7B USD
Net Margin
13%
Country US
Market Cap 65.9B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.8B USD
Net Margin
74%
Country CN
Market Cap 314.4B CNY
Net Margin
33%
Country US
Market Cap 36.4B USD
Net Margin
9%
No Stocks Found

Baxter International Inc
Glance View

Market Cap
14.9B USD
Industry
Health Care
Economic Moat
None

Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.

BAX Intrinsic Value
49.15 USD
Undervaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.8%
=
Net Income
108m
/
Revenue
14B
What is the Net Margin of Baxter International Inc?

Based on Baxter International Inc's most recent financial statements, the company has Net Margin of 0.8%.